ExploreWatchlistsPricing
  1. JP-listed companies
  2. VITAL KSK HOLDINGS,INC.
  3. Financials
  4. Accounts payable

VITAL KSK HOLDINGS,INC. (3151)

Market cap
¥78B
P/E ratio
9.8x
Vital KSK Holdings distributes pharmaceuticals to hospitals, pharmacies and veterinary practices while operating community pharmacies and healthcare services across Japan.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndAccounts payable (Million JPY)YoY (%)
Mar 31, 2025162,492-9.31%
Mar 31, 2024179,174+8.87%
Mar 31, 2023164,571-6.86%
Mar 31, 2022176,685+5.82%
Mar 31, 2021166,973-0.77%
Mar 31, 2020168,274-11.23%
Mar 31, 2019189,554+6.57%
Mar 31, 2018177,860+4.20%
Mar 31, 2017170,688-13.38%
Mar 31, 2016197,057+8.58%
Mar 31, 2015181,483

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat